Vanguard Group’s Ambrx Biopharma Inc AMAM Stock Holding History

Vanguard Group’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,399,642	Closed	-$19.9M	–	4512
2023 Q4	$19.9M	Buy	+1,399,642	New	+$15.9M	﹤0.01%	2599

Vanguard Group's AMAM Position: Q1 2024 in Review

Vanguard Group sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 1,399,642 shares — an estimated $19.9M sold.

Vanguard Group first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $19.9M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Vanguard Group reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Vanguard Group sold 1,399,642 Ambrx Biopharma Inc shares in Q1 2024, an estimated $19.9M.
Vanguard Group first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
Vanguard Group's Ambrx Biopharma Inc position peaked at $19.9M in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Vanguard Group's 13F filing for Q1 2024, filed 10 May 2024.